SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-759107
Filing Date
2016-11-04
Accepted
2016-11-03 17:37:57
Documents
72
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d204489d10q.htm 10-Q 499386
2 EX-10.1 d204489dex101.htm EX-10.1 3614
3 EX-31.1 d204489dex311.htm EX-31.1 8107
4 EX-31.2 d204489dex312.htm EX-31.2 8091
5 EX-32.1 d204489dex321.htm EX-32.1 3873
12 GRAPHIC g204489g1029001457733.jpg GRAPHIC 2442
  Complete submission text file 0001193125-16-759107.txt   3798448

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cara-20160930.xml EX-101.INS 699809
7 XBRL TAXONOMY EXTENSION SCHEMA cara-20160930.xsd EX-101.SCH 45246
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cara-20160930_cal.xml EX-101.CAL 62444
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cara-20160930_def.xml EX-101.DEF 178289
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20160930_lab.xml EX-101.LAB 386264
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20160930_pre.xml EX-101.PRE 290581
Mailing Address ONE PARROTT DRIVE SHELTON CT 06484
Business Address ONE PARROTT DRIVE SHELTON CT 06484 203-567-1500
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36279 | Film No.: 161972969
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences